Vanda Pharmaceuticals | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Arrowhead Research USD 369.62M 544.73M 2025-03
AstraZeneca USD 3.4B 1.74B 2025-03
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Insmed USD -255671000 21.39M 2025-03
J&J USD 13.63B 8.21B 2025-03
Ligand Pharmaceuticals USD -50180000 66.18M 2025-03
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Sanofi EUR 2.16B 20M 2025-03
Takeda JPY -107299000000 133.71B 2025-03
Teva Pharmaceutical Industries USD 294M 605M 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Veracyte USD 7.43M 3.98M 2025-03



Vanda Pharmaceuticals Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.